In 2001, Forever announced the world‟s first
ever double-blind, placebo controlled,
cross over, clinical trial for Irritable
Bowel Syndrome (IBS) using its Aloe Vera Gel drinking juice. The trial is being
conducted at the Morriston Hospital in South Wales. It is also developing
initiatives with other medical institutions in the UK to launch trials
involving a number of its Aloe Vera products for both internal and topical use.
Another clinical trial using the Aloe VeraGel drinking juice has been conducted at the Royal Free Hospital in London for
Ulcerative Colitis. 44 patients were involved in this trial with encouraging
results suggesting that further evaluation of the therapeutic potential of Aloe
Vera drink in inflammatory bowel disease is warranted
